Jos Buttler admits stakes high for England and his captaincy against Afghanistan
Football Daily | All cuts, no glory: Manchester United’s marginal gains with Ratcliffe
Lionesses frustrated, plus the Rubiales trial fallout – Women’s Football Weekly podcast
Chips in strips: Brentford move to stop counterfeit market in match-worn shirts
Italian priest close to the pope was target of high-level surveillance, he reveals
British drugmaker agrees payment to resolve 80,000 cases alleging cancers were linked to drug known generically as ranitidine
The British drugmaker GSK has struck an agreement to make a payment of up to $2.2bn (£1.7bn) to resolve litigation brought in the US over its heartburn treatment Zantac.
The company said it had struck agreements with 10 plaintiff law firms who represent about 93%, roughly 80,000, of the US state court product liability cases pending against it.
More Stories
Xi Jinping tells Alibaba’s Jack Ma and Chinese tech chiefs to ‘show their talent’
Hackers steal $1.5bn from crypto exchange in ‘biggest digital heist ever’
Nigeria sues crypto giant Binance for $81.5bn in economic losses and back tax